PULMONX CORPORATION (LUNG) Gross Margin
- Gross margin · 12 months: Value 77.06%; Formula and calculation Gross profit / revenue. Period ending 2026-06-30..
Gross margin
Overview →Financial period ending 2026-06-30; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| Gross margin · 12 months | 77.06% | Gross profit / revenue. Period ending 2026-06-30. $67.38M ÷ $87.44M × 100 ≈ 77.06% |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Gross profit | 67.38M USD | Gross Profit |
| Revenue | 87.44M USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Cost of products and services | 20.06M USD | Cost of Goods and Services Sold |
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Gross profit (USD) | Revenue (USD) | Cost of products and services (USD) | Gross margin |
|---|---|---|---|---|
| 2026-06-30 | $67.38M | $87.44M | $20.06M | 77.06% |
| 2026-03-31 | $66.84M | $88.55M | $21.70M | 75.49% |
| 2025-12-31 | $67.14M | $90.50M | $23.36M | 74.19% |
| 2025-09-30 | $67.19M | $91.66M | $24.48M | 73.30% |
| 2025-06-30 | $66.16M | $90.55M | $24.39M | 73.07% |
| 2025-03-31 | $64.27M | $87.47M | $23.21M | 73.47% |
| 2024-12-31 | $62.00M | $83.79M | $21.79M | 74.00% |
| 2024-09-30 | $58.81M | $79.30M | $20.49M | 74.16% |
| 2024-06-30 | $56.81M | $76.58M | $19.77M | 74.19% |
| 2024-03-31 | $54.24M | $72.99M | $18.75M | 74.31% |
| 2023-12-31 | $50.75M | $68.67M | $17.92M | 73.90% |
| 2023-09-30 | $47.54M | $64.82M | $17.29M | 73.33% |
| 2023-06-30 | $44.66M | $60.66M | $16.00M | 73.63% |
| 2023-03-31 | $42.34M | $57.41M | $15.07M | 73.75% |
| 2022-12-31 | $39.87M | $53.66M | $13.80M | 74.29% |
| 2022-09-30 | $38.93M | $51.95M | $13.01M | 74.95% |
| 2022-06-30 | $38.52M | $51.70M | $13.19M | 74.50% |
| 2022-03-31 | $37.13M | $49.96M | $12.83M | 74.32% |
| 2021-12-31 | $35.63M | $48.42M | $12.79M | 73.59% |
| 2021-09-30 | $32.46M | $44.54M | $12.08M | 72.87% |
| 2021-06-30 | $30.18M | $41.89M | $11.71M | 72.05% |
| 2021-03-31 | $22.16M | $33.36M | $11.20M | 66.44% |
| 2020-12-31 | $21.20M | $32.73M | $11.53M | 64.77% |
| 2020-09-30 | (m) | (m) | (m) | (m) |
| 2020-06-30 | $20.41M | $31.74M | (m) | 64.29% |
| 2020-03-31 | $24.35M | $35.44M | (m) | 68.71% |
| 2019-12-31 | $22.41M | $32.59M | $10.18M | 68.77% |
| 2019-09-30 | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) |
| 2019-03-31 | (m) | (m) | (m) | (m) |
| 2018-12-31 | $12.29M | $20.00M | $7.72M | 61.42% |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B |